The U.S. FDA’s approval of yet another indication for Dupixent (dupilumab), partnered between Regeneron Pharmaceuticals Inc. and Sanofi SA, could mean another $6.4 billion-plus in sales by the end of ...
WASHINGTON--(BUSINESS WIRE)--Today, the Partnership for Safe Medicines unveiled the results of a national public opinion poll that shows more than 90% of likely voters are concerned about the safety, ...